These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35274588)

  • 1. NT-proBNP and sRAGE levels in early rheumatoid arthritis.
    Heslinga M; Teunissen C; Agca R; van der Woude D; Huizinga T; van Laar J; den Broeder A; Lems W; Nurmohamed M
    Scand J Rheumatol; 2023 May; 52(3):243-249. PubMed ID: 35274588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
    Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
    Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
    Nguyen THP; Fagerland MW; Deyab G; Hjeltnes G; Hollan I; Feinberg MW; Eilertsen GØ; Mikkelsen K; Agewall S
    PLoS One; 2021; 16(6):e0253793. PubMed ID: 34170978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis.
    Solus J; Chung CP; Oeser A; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
    Arthritis Rheum; 2008 Sep; 58(9):2662-9. PubMed ID: 18759301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
    Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.
    Provan SA; Angel K; Odegård S; Mowinckel P; Atar D; Kvien TK
    Arthritis Res Ther; 2008; 10(3):R70. PubMed ID: 18573197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis.
    Targońska-Stępniak B; Majdan M
    Clin Rheumatol; 2011 Jan; 30(1):61-9. PubMed ID: 21110214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis.
    Shamsi A; Roghani SA; Soufivand P; Pournazari M; Khoobbakht F; Bahrehmand F; Taghadosi M
    Clin Rheumatol; 2024 Jan; 43(1):137-145. PubMed ID: 38006573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of N-terminal pro-brain natriuretic peptide in Takayasu arteritis disease monitoring.
    Liu Q; Dang A; Chen B; Lv N; Wang X; Zheng D
    J Rheumatol; 2014 Aug; 41(8):1683-8. PubMed ID: 25028376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator.
    Bradham WS; Ormseth MJ; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
    Inflammation; 2014 Jun; 37(3):801-8. PubMed ID: 24402421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study.
    Raadsen R; Dijkshoorn B; van Boheemen L; Ten Boekel E; van Kuijk AWR; Nurmohamed MT
    Joint Bone Spine; 2024 May; 91(3):105683. PubMed ID: 38161051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis.
    Welsh P; Tuckwell K; McInnes IB; Sattar N
    Atherosclerosis; 2016 Nov; 254():167-171. PubMed ID: 27744141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment].
    Gerasimova EV; Popkova TV; Martynova AV; Markelova EI; Novikova DS; Kirillova IG
    Ter Arkh; 2019 May; 91(5):34-39. PubMed ID: 32598674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
    Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
    J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study.
    Moraes JC; Ribeiro AC; Saad CG; Lianza AC; Silva CA; Bonfá E
    Clin Rheumatol; 2013 Jun; 32(6):879-83. PubMed ID: 23381669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tocilizumab on N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis without cardiac symptoms.
    Yokoe I; Kobayashi H; Kobayashi Y; Giles JT; Yoneyama K; Kitamura N; Takei M
    Scand J Rheumatol; 2018 Sep; 47(5):364-370. PubMed ID: 29804492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
    Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A
    Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.